Background: Tristetraprolin (TTP) and related proteins can bind to AU-rich elements in target mRNAs and promote their decay. Results: Certain AUF1 isoforms bound directly to TTP proteins and increased their affinity for RNA. Conclusion: Some AUF1 isoforms can act as "co-activators" of TTP protein binding to target mRNAs. Significance: Co-activation of TTP-mediated mRNA decay may modulate post-transcriptional gene expression.
Tristetraprolin (TTP) is the prototype of a family of CCCH tandem zinc finger proteins that can bind to AU-rich elements in mRNAs and promote their decay. TTP binds to mRNA through its central tandem zinc finger domain; it then promotes mRNA deadenylation, considered to be the rate-limiting step in eukaryotic mRNA decay. We found that TTP and its related family members could bind to certain isoforms of another AUrich element-binding protein, HNRNPD/AUF1, as well as a related protein, laAUF1. The interaction domain within AUF1p45 appeared to be a C-terminal "GY" region, and the interaction domain within TTP was the tandem zinc finger domain. Surprisingly, binding of AUF1p45 to TTP occurred even with TTP mutants that lacked RNA binding activity. In cell extracts, binding of AUF1p45 to TTP potentiated TTP binding to ARE-containing RNA probes, as determined by RNA gel shift assays; AUF1p45 did not bind to the RNA probes under these conditions. Using purified, recombinant proteins and a synthetic RNA target in FRET assays, we demonstrated that AUF1p45, but not AUF1p37, increased TTP binding affinity for RNA ϳ5-fold. These data suggest that certain isoforms of AUF1 can serve as "co-activators" of TTP family protein binding to RNA. The results raise interesting questions about the ability of AUF1 isoforms to regulate the mRNA binding and decay-promoting activities of TTP and its family members as well as the ability of AUF1 proteins to serve as possible physical links between TTP and other mRNA decay proteins and structures.
A physiological function for the CCCH tandem zinc finger protein tristetraprolin (TTP) 3 was initially uncovered through the analysis of TTP-deficient (KO) mice, which develop a severe inflammatory syndrome with erosive arthritis (1) . This syndrome is largely due to excessive production of tumor necrosis factor ␣ (TNF) (1) (2) (3) (4) . Macrophages derived from TTP-deficient mice produce more TNF than control cells after stimulation with LPS; overproduction of this protein is associated with increases in TNF mRNA (3) . The elevated steady state mRNA levels are largely due to the increased stability of the TNF mRNA (4) . Under normal circumstances, accelerated TNF mRNA decay occurs after binding of TTP to a specific type of AU-rich element (ARE) in the TNF mRNA 3Ј-untranslated region (4) . The physiological ability of TTP to promote the decay of ARE-containing transcripts can be modeled in cellular co-transfection systems, in which TTP is expressed along with an ARE-containing mRNA target (5) (6) (7) . A clue as to the mechanism of TTP-mediated mRNA decay came from the identification of a second physiological TTP target transcript, that encoding granulocyte-macrophage colony-stimulating factor (8) . In bone marrow-derived stromal cells from normal mice, the granulocyte-macrophage colony-stimulating factor transcript was detected on northern blots as two closely spaced bands of approximately equal intensity, whereas the transcript from the TTP KO mice was almost solely the larger of these two forms. The difference in the two species was the presence or absence of a poly(A) tail, with nearly all the granulocyte-macrophage colony-stimulating factor transcript in the TTP KO cells accumulating as the fully polyadenylated species, compared with about a 1:1 ratio of fully polyadenylated to deadenylated transcripts in the cells from the wild-type mice. This experiment identified removal of the poly(A) tail, or deadenylation, as likely to be the first event of TTP action after its RNA binding. Deadenylation is thought to be the rate-limiting step in mRNA decay in eukaryotes from yeast to man (9 -14) .
TTP is a member of a small protein family numbering four in the mouse. Null phenotypes have been described for two of the remaining three genes and include disrupted chorioallantoic fusion in the case of one family member, ZFP36L1 (15) , and disrupted hematopoiesis in the case of ZFP36L2 (16) . All members of the mammalian protein family seem to share the TTP ability to bind to ARE sequences and promote transcript deadenylation and decay (14) , suggesting that the mechanism by which TTP promotes deadenylation will be common to all of the mammalian family members.
In a search for TTP-binding proteins as potential modulators of TTP activity, we conducted yeast two-hybrid screens using human (h)TTP and its fragments as "bait" (17) . Among ϳ31 potential binding partners for human TTP (hTTP) identified by this screen, we recovered various fragments and isoforms of the protein known as HNRNPD or AUF1 (18 -22) . In this work we confirmed an interaction between hTTP and some isoforms of this protein as well as the related protein laAUF1 (23) by coimmunoprecipitation after expression in human embryonic kidney (HEK) 293 cells. The largest AUF1 isoform, AUF1p45, was found to bind to all TTP family members, apparently through its C-terminal GY region, whereas the smaller AUF1 isoforms lacking this region failed to bind. The region of TTP required for binding was the TZF domain; surprisingly, AUF1p45 binding to the TTP TZF domain also occurred in mutants incapable of RNA binding. AUF1p45 appeared to potentiate TTP binding to ARE-containing transcripts in cellfree assays. Like TTP, AUF1p45 was also found to bind to the poly(A) binding protein (PABP) (17) . These data suggest that TTP can bind ARE sequences in a transcript and recruit both AUF1p45 and PABP to the 3Ј-end of the transcript, in proximity to the poly(A) tail and various deadenylases. The AUF1 proteins may not only increase TTP binding to the ARE but also potentially serve as adaptors for other proteins involved in 3Ј-5Ј exonucleolytic decay of polyadenylated mRNAs.
MATERIALS AND METHODS
Yeast Two-hybrid Screening-Automated two-hybrid screening using ProNet technology was performed by Myriad Genetics, Salt Lake City, UT, as previously described (17, 24, 25) .
Plasmid Constructs-Construct HA-hTTP was as described previously (5) . Full-length tagged (HA or FLAG) cDNAs for human AUF1 isoforms, AUF1p37, AUF1p40, AUF1p42, and AUF1p45, were kindly provided by Dr. Robert J. Schneider and are described (26) . The plasmid containing full-length exon 7 (pFLAG-AUF1p45-X7) of human AUF1p45 (GenBank TM accession number NP_112738) was generated by PCR using plasmid DNA from construct FLAG-WT-AUF1p45 as a template. Various FLAG-tagged serial deletions within exon 7 of AUF1p45 (⌬327-333, ⌬ 324 -334, ⌬314 -334, ⌬304 -334, ⌬294 -334, and ⌬284 -334) were created by PCR using plasmid pFLAG-WT-AUF1p45 as a template and were cloned into HindIII and EcoRI sites of the FLAG-CMV2 vector (Sigma). Full-length cDNA of laAUF1 was obtained from GeneCopoeia, Inc, Rockville, MD) and cloned into HindIII and EcoRI sites of the FLAG-CMV2 vector. cDNAs encoding full-length human ZFP36L1, ZFP36L2, and mouse ZFP36L3 were subcloned into CMV.BGH3Ј/BSϩ and modified with N-terminal RGS-His 6 tags and C-terminal epitope tags, either HA or FLAG; tags were attached by insertion of oligonucleotide linkers into HindIIIand ApaI-digested CMV.BGH3Ј/BSϩ to create vectors pCMV-FLAG-BGH3Ј and pCMV-HA-BGH3Ј, respectively, using as templates I.M.A.G.E. clones obtained through Invitrogen. A PABP expression plasmid, CMV.hPABP.FLAG, was created as described (17) . The plasmid construct CMV.mTNF has been described previously (5) . The mutant expression constructs of HA-hTTP, namely, HA-hTTP 1-327 (C124R) and HA-TZF 96 -173, were generated by PCR using human WT HA-hTTP and are described elsewhere (13, 27) . Plasmid GFP-TTP has been previously described (28) . The expression plasmid HA-MARCKS (pBS-CMV/H80K-HA) was constructed by subcloning a 1.04-kb EcoRI/HindIII cDNA fragment of human MARCKS containing an HA tag into the EcoRI/HindIII sites of pBS-CMV and has been previously described (17) . The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA has been described (4) . Correct sequences of all plasmid inserts were confirmed by dRhodamine Terminator Cycle Sequencing (Perkin-Elmer Life Sciences).
Cell Culture, Transfections, Immunoprecipitations, and Western Blotting-HEK 293 cells were cultured and maintained in minimal essential medium (MEM; Invitrogen) supplemented with 10% fetal bovine serum, 100 units/ml penicillin, and 100 g/ml streptomycin. Transient transfection was performed using a standard calcium phosphate procedure (5) . After a further 24 h of incubation, cells were washed twice with ice-cold phosphate-buffered saline (PBS), and all liquid was removed by aspiration. Cells were lysed by direct addition to the culture dish of 600 l/10-cm dish of a lysis buffer containing 100 mM KCl, 20 mM HEPES-KOH (pH 7.6),10 mM MgCl 2 , 0.4% (v/v) Nonidet P-40, 10% (v/v) glycerol, 1 mM dithiothreitol,10 mM sodium molybdate, 5 mM NaF, 2.5 mM ␤-glycerophosphate, 1 mM phenylmethylsulfonyl fluoride, 5 g of pepstatin per ml, and 5 g of leupeptin per ml. Extracts were allowed to lyse on ice for 30 min, then clarified by centrifugation at 10,000 ϫ g for 30 min at 4°C.
Lysates used for immunoprecipitations were precleared with protein A-Sepharose 4B beads (GE Healthcare). None of the extracts used in this study was frozen before immunoprecipitation. All extracts were treated with RNase A before immunoprecipitation, as described earlier (17) . Briefly, this involved incubating the extracts with RNase A (Ambion) (5 g/100 g of extract protein) for 60 min on ice. The remaining extracts were stored at Ϫ80°C for immunoblotting. For immunoprecipitation, 1-2 mg of protein in the homogenization buffer was incubated overnight at 4°C with 4 g of anti-FLAG (Sigma), anti-HA (F-7, Santa Cruz Biotechnology, Santa Cruz, CA), or anti-GFP (B-2, Santa Cruz Biotechnology) monoclonal antibody and then added to 50 -100-l (packed volume) protein A-Sepharose 4B beads and mixed on a rotator (BD Biosciences) for 4 h at 4°C. Beads were sedimented by centrifugation at 1000 ϫ g for 1 min and washed gently 3 times with 1 ml of lysis buffer and once with 1 ml of lysis buffer without salt. SDS sample buffer was added directly to the beads.
Western blotting was performed using 50 -100 g of protein in cellular extracts mixed with a 1 ⁄ 5 volume of 5ϫ SDS sample buffer and boiled for 3 min, and then supernatant was loaded onto SDS-10% PAGE gels. Western blotting was performed by standard techniques (17, 29) using anti-FLAG or anti-HA or anti-GFP antibody directly coupled to horseradish peroxidase (Santa Cruz Biotechnology).
Cloning and Purification of Recombinant Fusion ProteinsThe insert containing GFP-TZF.hTTP (amino acids 102-174) of human TTP was excised from pEGFP-TZF.TTP (28) and cloned into the PET30a(ϩ) vector (EMD Biosciences, Inc., NJ) to create peGFP-His-6/PET30a(ϩ); this was renamed GFPHis-TZF (hTTP). The creation of plasmids His-AUF1p45 and AUF1p37 have been described (30) . Purification of these recombinant proteins has also been described (30, 31) . GFPHis-TZF (hTTP) was purified using the HisPur Ni-NTA Resin kit from Thermo Scientific, Rockford, IL, as per the manufacturer's instructions. Eluted His-tagged proteins were reconstituted before use in 50 mM HEPES (pH 8.0), 15 mM imidazole, and 30 mM NaCl.
Co-immunoprecipitation and Immunoblotting of Purified Proteins-To test the direct binding of recombinant-purified proteins (see below), proteins (1.0 g each) were gently resuspended in 100 l of ice-cold binding buffer containing 25 mM Tris (pH 8.0), 10% glycerol, 100 mM NaCl, 0.01% Nonidet P-40, 3 mM MgCl 2 , 0.1 mM PMSF, 1 g/ml aprotinin, and 5 g/ml leupeptin. Co-immunoprecipitation was performed by the addition of antibodies (0.5 g) including anti-AUF1p45 (#7271, a generous gift from Dr. Gary Brewer), an anti-GFP (B-2) (Santa Cruz Biotechnology) monoclonal antibody, or rabbit anti-IgG. The mixtures were incubated with rotation for 4 h at 4°C. The protein-antibody complexes then were adsorbed onto protein A-Sepharose and protein G-agarose beads (Santa Cruz Biotechnology) by incubating the mixture overnight at 4°C in a final volume of 500 l of binding buffer. The beads were collected by centrifugation and washed gently three times with binding buffer containing protease inhibitors. The beads were then suspended in SDS-sample buffer and heated for 5 min at 95°C. The soluble proteins were separated by 10% SDS-PAGE, and the transferred blots were probed with anti-GFP-HRP or rabbit polyclonal anti-His (His-Probe H15) (Santa Cruz Biotechnology). The secondary antibody used for anti-His immunoblot was goat anti-rabbit-HRP (Bio-Rad).
Northern Blotting-Separate transfection experiments were conducted for Northern analysis. Briefly, HEK 293 cells were maintained and transfected as described above. Twenty-four hours after removal of the transfection mixture, total cellular RNA was harvested from the HEK 293 cells with an Illustra RNAspin mini RNA isolation kit (GE Healthcare).
Northern blots were prepared as described elsewhere (5). Blots were hybridized to a randomly primed, ␣-32 P-labeled mTTP cDNA (5) or a ϳ1-kb NarI-BglII fragment of mouse (m) TNF cDNA. Some blots were also hybridized to an ␣-32 P-labeled glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA probe (4) or with a ϳ1-kb HindIII-EcoRI fragment of FLAG-AUF1p45 construct (19) .
RNA Electrophoretic Mobility Shift Assays-For RNA electrophoretic mobility shift assays (RNA-EMSA), cell extracts were prepared as follows. Cells were scraped from 10-cm dishes into ice-cold PBS, combined as needed, and centrifuged at 600 ϫ g for 3 min at room temperature. The PBS was aspirated, and cells were gently resuspended in a hypotonic lysis buffer (0.2% (v/v) Nonidet P-40, 10 mM KCl, 3 mM MgCl 2 , and 10 mM Hepes-NaOH (pH 7.6)) supplemented with protease inhibitors as above and incubated on ice for 15 min. Extracts were clarified by centrifugation at 22,000 ϫ g for 15 min at 4°C, the KCl concentration was adjusted to 50 mM, and glycerol was added to a final concentration of 10% (v/v). RNA-EMSA assays were performed essentially as described (17) . Briefly, cytosolic extracts (0.1 to 5.0 g of protein) prepared from HEK 293 cells transfected with vector alone or with expression constructs driven by the CMV promoter were incubated with 0.6 ng of 5Ј biotinlabeled (Invitrogen) human TNF-ARE probe (5Ј-biotin-UUAUUUAUUUAUUAUUUAUUUAUU-3Ј) derived from the TNF 3Ј-UTR (bp 1309 -1332 of GenBank TM accession number X02611) at room temperature for 30 min in 20 l of lysis buffer (without protease inhibitors) containing 10 mM Hepes (pH 7.6), 40 mM KCl, 2.5% (v/v) glycerol, and 3 mM MgCl 2 . Heparin and yeast tRNA were added to final concentrations of 2.5 and 50 ng/l, respectively, for an additional 10 min. RNA not associated with protein was digested with 100 units of RNase T 1 for 20 min at room temperature; the reaction mixture was then loaded onto a 6% nondenaturing acrylamide gel and subjected to electrophoresis at 160 V for 90 min in 0.4 ϫ Tris borate-EDTA buffer. Gels were transferred to Biodyne B nylon membranes (0.45 m) (Thermo Scientific, IL) in 0.4 ϫ Tris borate-EDTA buffer at 80 V for 1 h. Unbound probe and RNAprotein bound signals were detected using a stabilized streptavidin-HRP conjugated antibody in a chemiluminescent nucleic acid detection module kit (Thermo Scientific) as per the manufacturer's instructions and exposed to BIOMAX MR films from Eastman Kodak Co. Shifted bands in the gel shift assays were quantitated using ImageQuant biomolecular imager 4010 software (GE Healthcare).
Assays of RNA Binding Using Steady State Fluorescence Resonance Energy Transfer (FRET)-Association of recombinant
GFP-TTP-TZF protein with a cyanine 5 (Cy5)-labeled RNA substrate was quantified using a FRET-based assay. Briefly, GFP-TTP-TZF (1 nM final) was incubated at 30°C in the absence and presence of increasing concentrations of the Cy5-labeled ARE substrate Cy5-ARE 11 (5Ј-Cy5-UUUAUU-UAUUU-3Ј) or an unlabeled ARE substrate (ARE 13 ; 5Ј-AUU-UAUUUAUUUA-3Ј), which the TTP TZF domain binds with high affinity (32) . Reactions (2 ml final) were assembled in 10 mM Tris-HCl (pH 8.0) containing 50 mM KCl, 2 mM dithiothreitol, 5 M ZnCl 2 , and 0.1 g/l acetylated bovine serum albumin. Heparin (0.2 g/l) was added to minimize nonspecific RNA-binding activity. Reactions lacking ZnCl 2 contained 0.5 mM EDTA to scavenge residual divalent cations. Where indicated, recombinant His 6 -tagged AUF1 proteins were added to a final concentration of 10 nM.
Fluorescence of binding reactions was measured using a Cary Eclipse fluorescence spectrophotometer (Varian) equipped with a temperature-controlled sample block. Excitation was set to 485 nm, and emission spectra measured from 500 to 750 nm, with 10-nm slit widths for both monochromators. For each binding reaction, FRET efficiency (E FRET ) was calculated from paired measurements of emission from the FRET donor (GFP-TTP-TZF) at 520 nm in the presence (F DA ) and absence (F D ) of the Cy5-labeled RNA substrate using the equation E FRET ϭ 1 Ϫ (F DA /F D ). E FRET is inversely related to the scalar distance between the fluorescent donor and the acceptor and is, therefore, enhanced when the fluorophores are in close proximity or are subunits in the same complex (for review, see Ref. 33 ). Accordingly, measured values of E FRET rise as the GFP-TTP-TZF peptide shifts from unbound to Cy5-ARE 11 -bound states. Because of the very high affinity observed for GFP-TTP-TZF binding to RNA, associated equilibrium binding constants (K) were resolved by nonlinear regression of plots of E FRET versus Cy5-ARE 11 RNA substrate concentration using PRISM v3.03 software (GraphPad) and the Equation 1,
This function resolves the transition of measured E FRET values from unbound GFP-TTP-TZF (E P Ϸ 0) to the saturated GFP-GFP-TTP-TZF⅐Cy5-ARE 11 complex (E PR ) in terms of total protein ([P] t ) and RNA ([R] t ) concentrations (34). Equilibrium dissociation constants were then calculated as K d ϭ 1/K. Comparisons between binding constants were performed using the unpaired t test, with differences of p Ͻ 0.05 considered significant.
RESULTS

Identification of AUF1 Isoforms as hTTP Binding
ProteinsDetails of the initial two-hybrid screens using hTTP or its fragments as bait have been described (17) . We found that fulllength hTTP was found to be self-activating in the two hybrid screen, and so several hTTP fragments were expressed instead as bait. Some of the 31 proteins identified as potential TTP binding partners in these screens have been described previously (17) . Among others were members of the HNRNPD or AUF1 protein family (18, 35, 36) as well as a related protein, laAUF1 (GenBank TM RefSeq accession number NP_112740). In all cases the fragment of hTTP that recognized AUF1 proteins in the two-hybrid screen included the TZF domain, spanning amino acids 103-166 of GenBank TM accession number NP_003398.1; specifically, bait comprising hTTP amino acid sequences 50 -180 or 90 -180 identified sequences from AUF1p42 (NP_112737; residues 132-336) from a breast cancer/prostate cancer library and a spleen library; AUF1p45 (NP_112738; residues 82-355) from the spleen library; AUF1p40 (NP_002129; residues 46 -306) from the breast cancer/prostate cancer library; and laAUF1 (HNRNPD-L) (NP_112740; residues 90 -388) from both the breast cancer/ prostate cancer and spleen libraries. These data are summarized in supplemental Table 1 .
Confirmation of Interaction between hTTP and AUF1 Isoforms-We next co-expressed hTTP with various isoforms of AUF1 in cultured HEK 293 cells in an attempt to demonstrate physical association by co-immunoprecipitation. These cells are a convenient test system because they do not express significant levels of any of the TTP family members. We used PABP as a positive control for hTTP binding and MARCKS as a negative control as described previously (17) . Immunoprecipitations (IP) were performed using anti-HA or anti-FLAG antibodies followed by Western blotting with the appropriate epitope-tag antibodies. We first checked the expression of hTTP, the largest isoform of AUF1, AUF1p45, PABP, and MARCKS proteins in the transfected cells by immunoblot analysis of whole cell lysates (WCL) with HRP-conjugated anti-HA (Fig. 1A) or anti-FLAG antibodies (Fig. 1B) . Immunoprecipitations from these lysates were then performed using anti-HA or anti-FLAG antibodies. Using anti-HA antibodies in the immunoprecipitation reactions (Fig. 1C) , we found that immunoprecipitation of HA-AUF1p45 brought down FLAG-hTTP (Fig.  1C, lane 4) ; this was not seen when the same extract was immunoprecipitated with normal rabbit serum (NRS) (Fig. 1C, lane  5) . As a positive control, HA-hTTP could bring down FLAG-PABP (Fig. 1C, lane 12) . HA-AUF1p45 also brought down FLAG-PABP, even in the absence of co-transfected hTTP (Fig.  1C, lane 7) .
When anti-FLAG antibodies were used in the immunoprecipitation reactions (Fig. 1D ), FLAG-hTTP was able to bring down HA-tagged AUF1p45 (Fig. 1D, lane 4) but not when normal rabbit serum was used in place of the immune serum (Fig.  1D, lane 5) . As a positive control, FLAG-PABP was able to pull down HA-hTTP (Fig. 1D, lane 12) ; it also could pull down HA-AUF1p45 (Fig. 1D, lane 7) . As a negative control, FLAGhTTP did not bring down HA-MARCKS (Fig. 1D, lane 10) . These results confirm that hTTP can bind to PABP, as shown previously (17) , and a new finding is that AUF1p45 can bind separately to PABP. Most importantly, the data show that hTTP could associate with AUF1p45 under these conditions.
Interaction of hTTP with AUF1p42 and AUF1p45 but Not with AUF1p37 or AUF1p40-We next tested whether hTTP could interact directly with other isoforms of AUF1, namely AUF1p37, AUF1p40, and AUF1p42 (36) . We co-transfected cDNAs encoding full-length HA-hTTP and various FLAGtagged AUF1 isoforms into human HEK 293 cells and attempted to co-immunoprecipitate complexes using both HA and FLAG antibodies. Expression of HA-tagged hTTP and the four FLAG-tagged AUF1 isoforms was confirmed in the WCL by immunoblotting with anti-HA (Fig. 2A1 ) and anti-FLAG (Fig. 2A2) antibodies, respectively. As before, FLAG-AUF1p45 could bring down HA-hTTP (Fig. 2A3, lane 10) as did FLAGAUFp42 (Fig. 2A3, lane 9) . In contrast, neither FLAG-AUFp40 nor FLAG-AUFp37 brought down HA-hTTP (Fig. 2A3, lanes 7  and 8) . Similarly, HA-hTTP was able to bring down FLAGAUF1p42 and FLAG-AUF1p45 (Fig. 2A4, lanes 9 and 10) but not FLAG-AUF1p37 or FLAG-AUF1p40 (Fig. 2A4, lanes 7 and  8) . Again, there was no apparent nonspecific immunoprecipitation of HA or FLAG-tagged proteins with empty vectors.
We also tested a potential interaction between hTTP and the AUF1-related protein, laAUF1, an interaction that was identified by the two-hybrid screen. Expression of both HA-hTTP (Fig. 2B1, lanes 2 and 4) and FLAG-laAUF1 (Fig. 2B2, lanes 3  and 4) were confirmed in lysates of transfected cells. Immunoprecipitation with the anti-HA antibody, targeting HA-hTTP, was able to pull down FLAG-laAUF1 (Fig. 2B3, lane 4) , whereas there was no apparent immunoprecipitation of FLAG-laAUF1 protein from cells transfected with the HA empty vector (Fig.  2B3, lane 3) .
We next compared the domain structures of all four AUF1 isoforms and laAUF1 (Fig. 2C) . Only a region near the C terminus corresponding to the 49 amino acids derived from exon 7 in AUF1, labeled a GY region (18) , was present in the three proteins that interacted with hTTP, AUF1-p42, AUF1p45, and laAUF1 but was absent in the non-interacting isoforms AUF1-p37 and AUF1-p40 (Fig. 2C) . These data suggested that the domain responsible for the interaction with hTTP is in or near the GY region, derived from exon 7 of the gene encoding AUF1p45, comprising amino acid residues 285-333 of GenBank TM RefSeq NP_112738.1. To test whether the sequences within the GY region were responsible for TTP binding, we made FLAG-tagged mutants of AUFp45 with serial deletions of amino acids from within the GY region. We also made a construct containing only the intact GY region (49 amino acids) of AUFp45. These mutant proteins were then co-expressed with hTTP and co-immunoprecipitated (Fig. 2D) . Expression of HA-tagged hTTP and FLAGtagged AUF1p45 and its various mutants were confirmed in the WCL by immunoblotting with anti-HA antibody (Fig. 2D1 ) and in anti-FLAG immunoprecipitates by immunoblotting (Fig.  2D2) . As before, full-length FLAG-AUF1p45 could bring down HA-hTTP (Fig. 2D3, lane 1) . Two of the deletion mutants with relatively small deletions at the C-terminal end of the GY region exhibited much weaker binding to hTTP (Fig. 2D3, lanes 2 and  3) ; the larger deletions exhibited no detectable binding under these conditions (Fig. 2D3, lanes 4 -7) . The FLAG-tagged intact GY region alone was able to bind to hTTP (Fig. 2D3, lane 8) . These data suggest that the intact GY region of AUF1p45 is both necessary and sufficient for the interaction of AUF1p45 with hTTP.
Interaction of hTTP with AUF1p45 through Its TZF DomainBecause in the two-hybrid screen two baits of hTTP comprising amino acids 50 -180 and 90 -180 of NP_003398.1, spanning the TZF domain (amino acids 103-166), identified multiple prey clones containing three large protein fragments from various AUF1 isoforms and one fragment of the la-AUF1 protein encoded by the HNRNPDL gene, we predicted that the TZF region of hTTP would interact directly with the AUF1 proteins. To test this, we expressed HA-tagged, full-length hTTP, its non-RNA binding mutant hTTP/C124R (37), and its TZF domain alone and tested their ability to pull down full-length AUF1p45 in a co-immunoprecipitation assay. In this experiment, HA-tagged versions of each of the TTP constructs were co-expressed with FLAG-AUF1p45 in HEK 293 cells, and the proteins were immunoprecipitated using an anti-HA antibody.
The expression of HA-hTTP and its mutant derivatives and FLAG-tagged AUF1p45 were confirmed in the WCL by anti-HA (Fig. 3A1 ) and anti-FLAG immunoblotting (Fig. 3A2) , respectively. These extracts were then immunoprecipitated using the anti-HA antibody, and the pellets were subjected to immunoblotting with the anti-FLAG antibody (Fig. 3A3) . As demonstrated above, full-length HA-hTTP was able to pull down FLAG-AUF1p45 (Fig. 3A3, lane 2) . FLAG-AUF1p45 was also brought down by the HA-hTTP mutant (1-327/C124R), a mutant full-length protein that does not bind RNA (37) (Fig.  3A3, lane 3) . The HA-tagged TZF domain of hTTP alone was also able to pull down FLAG-AUF1p45 (Fig. 3A3, lane 4) . These results support the initial findings of the two-hybrid screen and demonstrate that hTTP can bind to AUF1p45 through its RNA binding TZF domain. It also appears that the RNA binding activity of TTP is not necessary for this interaction, as a non-RNA binding TTP mutant, C124R, retained TTP ability to bind AUF1p45 protein (Fig. 3A3, lane 3) .
To test whether the interaction between hTTP and AUF1p45 is direct, we performed binding reactions using purified recombinant fusion proteins (Fig. 3, B1 and B2) . Recombinant AUF1p45 was found to bind directly to the recombinant GFP-TZF fusion protein of hTTP (Fig. 3, B1, lane 1, and B2, lane1) . No nonspecific binding was seen in the IgG control IPs (Figs. 3, (Figs. 3, B1  and B2, lanes 1-3) .
B1, lane 2, and B2, lane 2) and in IgG immunoblots
Binding of Other TTP Family Members to AUF1p45-To determine whether the other human TTP family members hZFP36L1 and hZFP36L2 and mouse (m) ZFP36L3 could interact with AUF1p45, we co-transfected cDNAs encoding fulllength, epitope-tagged proteins into HEK 293 cells and evaluated complex formation by co-immunoprecipitation followed by Western blotting. The expression of the various proteins in the WCL was confirmed by immunoblotting with anti-FLAG antibodies (Fig. 4, 1) and anti-HA antibodies (Fig. 4, 2) . As shown in Fig. 4, 3 , FLAG-AUF1p45 was pulled down by HAhTTP (Fig. 4, 3, lane 2) , HA-hZFP36L1 (Fig. 4, 3, lane 3) , and HA-hZFP36L2 (Fig. 4, 3, lane 4) , and FLAG-mZFP36L3 (FLAG-mouse zinc finger protein 36-like 3) was pulled down by HA-AUF1p45 (Fig. 4, 3, lane 6 ). There was no detectable precipitation of FLAG-AUF1p45 or other FLAG-tagged proteins in cells transfected with empty vectors (Fig. 4, 3, lanes 1 and 5) . These results demonstrate that AUF1p45 can bind to all known mammalian TTP family members, presumably reflecting the high degree of amino acid conservation in their TZF domains (38, 39) .
Effect of Co-expression of AUF1p45 with hTTP on TNF mRNA-To test whether AUF1p45 co-expression affected the TTP ability to promote ARE-containing mRNA decay in intact cells, we co-transfected plasmids into HEK 293 cells, which do not express detectable levels of TNF or TTP mRNAs (5). In the absence of transfected hTTP DNA, the reporter RNA was detected on northern blots as a single major band (Fig. 51, lane  2) . When a low concentration of hTTP DNA (5 ng) was transfected with this reporter, the accumulation of the TNF reporter mRNA was markedly decreased along with the appearance of a smaller species that is thought to represent the deadenylated form of the transcript (Fig. 5, 1, lane 3) . At higher levels of transfected hTTP DNA concentrations (50 -500 ng; Fig. 5, 1,  lanes 4 -6) , both the polyadenylated and deadenylated transcripts began to accumulate, a finding we have attributed to protection of both forms of mRNA by excess concentrations of TTP (5). These findings are similar to those reported earlier with this combination of transfected DNAs (5) .
A modest increase in expression of AUF1p45 over basal did not appear to affect the level or polyadenylation status of the TNF-based reporter transcript under these conditions (Fig. 5, 1 , compare lane 8 to lane 2). When AUF1p45 was co-expressed with the lowest concentration of hTTP DNA, the decreased total mRNA accumulation along with the presence of the deadenylated transcript appeared to be very similar to the results obtained in the absence of co-transfected AUF1p45 (compare Fig. 5, 1, lane 9 to lane 3) . At higher TTP concentrations, the presence of AUF1p45 did not interfere with the increased accumulation of both the polyadenylated and deadenylated species of reporter mRNA (Fig. 5, 1, compare lanes 10 -12 to lanes  4 -6) . The expression of the transfected-expressed hTTP mRNA is shown in Fig. 5, 2, lanes 3-6 and 9 -12) , and that of AUF1p45 mRNA is shown in Fig. 5, 3, lanes 8 -12) . Note the modest and constant expression of endogenous AUF1p45 in the blots at a slightly greater apparent size than the transfectedexpressed transcript in all lanes of Fig. 5, 3 . The expression of endogenous GAPDH mRNA, used as a loading control in this experiment, is shown in Fig. 5, 4, lanes 1-12) . These studies FIGURE 4 . Binding of other TTP family members to AUF1p45. Abbreviations and other details are as described in the legend to Fig. 1 . FLAG-AUF1p45 was expressed with various TTP family member constructs. The expressed TTP-related proteins ZFP36L1 and ZFP36L2 were the human proteins, whereas the expressed ZFP36L3 was the mouse protein. suggest that, at these modestly increased levels of AUF1p45 expression, there were no obvious effects on TTP ability to promote TNF-based mRNA decay in this co-transfection system.
Effect of AUF1p45 on hTTP Binding to TNF-based RNA Probe-The RNA binding activity of hTTP is essential for initiation of mRNA decay. To determine whether there was any effect of the interaction between AUF1p45 and hTTP on the RNA binding ability of hTTP, we performed several types of RNA gel shift assays using cytosolic extracts containing varying concentrations of AUF1p45 and hTTP alone or together using a TNF-based ARE RNA probe containing four clustered UUAUUUAUU motifs (residues 1309 -1332, GenBank TM accession number NM_013693.2). Incubation of this probe with a cytosolic extract prepared from HEK 293 cells transfected with vector alone (Bluescript) did not shift detectable amounts of RNA probe into the gel (Fig. 6A1, lane 2 ). An extract from cells transfected with the FLAG-AUF1p45 expression FIGURE 6 . Effects of AUF1p45 on hTTP binding to a TNF-based RNA probe. Cytosolic extracts of HEK 293 cells transfected with vector alone (BS) or vectors expressing HA-hTTP alone or Flag-AUF1p45 alone were used in RNA gel shift analyses using a 5Ј-biotin-labeled TNF ARE-based RNA probe. A shows RNA gel shifts using protein extracts/cell lysates containing identical amounts of empty vector-transfected cytosolic protein and decreasing amounts of FLAGAUF1p45 incubated in the presence or absence of a constant concentration of FLAG-hTTP. The migration positions of the hTTP-ARE complexes and that of the RNA probe alone are indicated with arrows to the right of Fig. 6A1. 6A2 shows an immunoblot performed with 10 times the amount of cellular proteins as used in the gel shift analysis from the same cellular extracts (A1 and B1), demonstrating expression of the epitope-tagged proteins. B1 shows a gel shift analysis in which extracts containing a constant amount of cellular protein (1 g) with or without FLAG-AUF1p45 were incubated with varying amounts of FLAG-hTTPcontaining cell extracts (1.0 to 0 g). The asterisks indicate endogenous HEK 293 cell proteins that could shift small amounts of probe in the absence of hTTP. Shown in B2 is the graphic representation of the results of four experiments identical to that shown in B1, shown as the means Ϯ S.E. Asterisks indicate statistical differences between the means of each pair at p Ͻ 0.05. Below the histogram are shown the corresponding gel lanes in B1, and the amount of cell extracts of each type used in the gel shift experiments. See "Results" for further details. C1 shows a gel shift analysis in which FLAG-hTTP-containing HEK 293 cellular extracts in varying amounts (1.0 -0 g) with or without a constant amount of purified recombinant His-AUF1p45 (20 ng) were incubated together. The asterisks indicate endogenous HEK 293 cell proteins that could shift small amounts of probe in the absence of hTTP. The thick arrow on the left indicates the quantitated area of the shifted ARE-protein complex. C2 is the graphic representation of the results of three experiments identical to that shown in C1, shown as the means Ϯ S.E. Asterisks indicate statistical differences between the means of each pair at p Ͻ 0.05. Below the histogram are shown the corresponding gel lanes in C1 and the amount of cell extracts of each type used in the gel shift experiments. Abbreviations and other details are as described in the legend to Fig. 1 . NS, non-specific. See "Results" for further details.
construct was serially diluted with an extract from cells transfected with the Bluescript vector alone that contained the identical concentration of cytosolic protein; the amount of protein from the FLAG-AUF1p45-containing extract used in each reaction is indicated at the top of each gel lane (Fig. 6A1, lanes  3-8) . No detectable probe was shifted into the gel under these conditions (Fig. 6A1, lanes 3-8) . An identical experiment was repeated in the presence of a constant amount of hTTP-containing extract (1 g/lane) (Fig. 6A1, lanes 9 -14) . hTTP in the absence of AUF1p45 shifted most but not all of the RNA probe into the gel (Fig. 6A1, lane 14) . When the lysates containing varying concentrations of AUF1p45 were mixed with the lysates containing hTTP (1 g), the ability of hTTP to shift the probe into the gel appeared to be modestly enhanced at all FLAG-AUF1p45 concentrations (Fig. 6A1, compare lanes 9-13  with lane 14) . Fig. 6A2 documents the expression of both epitope-tagged proteins in the cytosolic extracts used in this experiment; each lane contained 10 times more protein than the amounts used in the gel shift assays in Fig. 6 , A1 and B1.
We next mixed various concentrations of FLAG-hTTP extracts with cytosolic extracts that contained varying ratios of cytosol from vector-transfected cells and cells transfected with the FLAG-AUFp45 vector (Fig. 6B1) . Lysate containing the most hTTP alone (1 g of extract protein) produced a single major hTTP-ARE complex (Fig. 6B1, lane 2) . Lysates containing decreasing amounts of hTTP (in the absence of AUF1p45) exhibited progressively less binding to the probe (Fig. 6B1, lanes  2-5) . In the absence of hTTP, the extract from vector-transfected cells yielded three faint shifted bands from endogenous HEK 293 cell proteins (Fig. 6B1, lane 6; asterisks) . When the identical experiment was performed in the presence of a constant amount of AUF1p45, there appeared to be an increase in TTP binding to the ARE probe at each concentration of hTTP (Fig. 6B1, lanes 7-10) .
In these experiments we quantitated the extent of gel shift using an ImageQuant biomolecular imager considering the TTP-alone lane at the highest concentration (e.g. Fig. 6B1 , lane 2) as 100%. We performed several identical experiments, and the data from the gel shift analyses were quantitated and shown in Fig. 6B2 . Statistical comparisons of the probe binding to TTP in the presence and absence of AUF1p45 demonstrated significant increases in the binding of TTP to the RNA probe in the presence of AUF1p45 (Fig. 6B2 ).
Finally, we tested whether purified recombinant AUF1p45 could potentiate TTP binding to the RNA probe. In this experiment, a constant amount of purified recombinant AUF1p45 protein was mixed with cytosolic extracts containing varying concentrations of hTTP using the same TNF-based ARE RNA probe containing four clustered UUAUUUAUU motifs (Fig.  6C1) . The lysate containing the most hTTP alone (1 g of extract protein) produced a major, slower migrating hTTP-ARE complex (Fig. 6C1, lane 2, top band) as well as smaller amounts of more rapidly migrating complexes that were identical to endogenous protein complexes seen in the control cell extract (asterisk, see Fig. 6C1, lane 8) . With decreasing amounts of hTTP, there was progressively less binding to the probe (Fig.  6C1, lanes 3-8) as evidenced by decreases in the top band, accumulation of the endogenous protein complexes, and increasing amounts of unshifted probe (Fig. 6C1, lanes 2-8) . When the identical experiment was performed in the presence of a constant amount of purified recombinant AUF1p45 protein (20 ng), AUF1p45 alone did not shift this probe into the gel (Fig. 6C1, lane 15) . However, in the presence of AUF1p45, there was an increase in TTP binding to the ARE probe at each concentration of hTTP (Fig. 6C1, lanes 9-14) . Fig. 6C2 summarizes the data from several such experiments in which we quantitated the extent of the hTTP-probe complex formation using an ImageQuant imager, considering the TTP alone lane at the highest concentration (e.g. Fig. 6C1, lane 2) as 100%. Statistical comparisons of the probe binding to TTP in the presence and absence of AUF1p45 are shown in Fig. 6C2 and demonstrate markedly and significantly increased TTP binding to the RNA probe in the presence of purified recombinant AUF1p45 protein.
Effect of AUF1p45 to Enhance the Binding of GFP-TTP-TZF to ARE Target-The association of purified, recombinant GFP-TTP-TZF with an 11-nucleotide ARE substrate was monitored by FRET between the GFP moiety of the fusion protein and a 5Ј-Cy5 group conjugated to the RNA (Fig. 7A) . FRET was demonstrated in the ribonucleoprotein complex by decreased fluorescence from the GFP-TTP-TZF protein as the concentration of the Cy5-ARE 11 substrate increased in addition to enhanced emission from the Cy5 dye (Fig. 7B) . Decreased GFP-TTP-TZF emission was not a photophysical consequence of RNA binding, as the emission spectrum from this protein was unaffected by binding to an unlabeled RNA substrate (Fig. 7C) . Furthermore, GFP-TTP-TZF binding to the ARE substrate was dependent on correct folding of the TZF domain, as Cy5-ARE 11 did not induce FRET in reactions containing 0.5 mM EDTA in place of Zn 2ϩ (data not shown). Monitoring FRET efficiency of the GFP-TTP-TZF⅐Cy5-ARE 11 complex as a function of RNA substrate concentration permitted quantitative resolution of equilibrium binding parameters (Fig. 7D) . In the absence of AUF1 proteins, GFP-TTP-TZF binding to the Cy5-ARE 11 substrate exhibited a K d of 550 Ϯ 60 pM (n ϭ 6). However, the addition of purified recombinant His-AUF1p45 (10 nM) to the binding reaction enhanced GFP-TTP-TZF binding to the RNA target by nearly 5-fold (K d ϭ 120 Ϯ 20 pM, n ϭ 6, p Ͻ 0.0001 versus no AUF1). The stimulatory effect of AUF1 was isoform-specific, as the addition of His-AUF1p37 (10 nM) did not improve GFP-TTP-TZF⅐Cy5-ARE 11 binding affinity (K d ϭ 810 Ϯ 160 pM, n ϭ 3).
DISCUSSION
TTP and its family members are CCCH TZF proteins that can bind to ARE-containing transcripts and destabilize them. In the absence of TTP in mice, target transcripts such as those encoding TNF accumulate, leading to a complex inflammatory syndrome of TNF excess (1). Our current understanding of TTP action is that first TTP binds through its TZF domain to ARE sequences in mRNAs; this is then followed by accelerated deadenylation of the transcripts (7, 8, 14) . Because deadenylation is thought to be the first and rate-limiting step of mRNA decay in eukaryotes (40 -42) , this step is thought to lead to further, complete mRNA decay by processes involving other nucleases and exosome components (43) .
One important finding of this study is that the two largest isoforms of the well known ARE-binding protein AUF1/HN-RNPD, AUF1p42 and AUF1p45, as well as a related protein, laAUF1, could bind directly to TTP and its family members, apparently through their TZF domains. Remarkably, this occurred even with TTP mutants that were unable to bind RNA due to mutations in the TZF domain. This coincided with our use of RNase A in the standard co-immunoprecipitation reactions; both results demonstrate that the protein-protein interactions could occur in the absence of a "bridging" RNA moiety. Binding to TTP did not occur with the two smaller AUF1 isoforms tested, AUF1p37 and AUF1p40. These two isoforms lack the ϳ49 amino acid C-terminal glycine and tyrosine rich (GY) domain, which is contributed by exon 7 in the AUF1p45 isoform. This domain was both necessary and sufficient to bind to TTP. Taken together, the data demonstrate that the GY domain of the longer AUF1 isoforms as well as laAUF1 served as the TZF binding domain.
A second important finding is that the interaction between the longer isoforms of AUF1 and TTP actually increased the affinity of the latter for its target RNA sequences. This was demonstrated with intact fusion proteins in cell-free extracts as well as in a cytosol-free FRET assay using only purified recombinant proteins and fluorescently labeled RNA. In contrast, AUF1p37 did not potentiate TTP-RNA binding. We found no evidence that even the longer AUF1 isoforms such as AUF1p45 bound to the ARE-containing RNA targets used. A recent discussion of the RNA target sequence for AUF1 demonstrated the need for a considerably longer AU-rich sequence than that used by TTP; this binding consensus sequence was notable for its prominent predicted secondary structure (44) . In contrast, a major conclusion deriving from the structure of TTP family TZF domains bound to RNA was that the binding occurred in the absence of RNA secondary structure (45) . The lack of AUF1 binding to the ARE probe used in our studies could represent either an inadequate primary sequence or inadequate secondary structure of this probe.
Taken together these results allow us to propose that the longer AUF1 isoforms and laAUF1 can serve as co-activators of TTP family member binding to mRNA target sequences. In this role the AUF1 proteins could be expected to potentiate TTP family protein activities to promote target mRNA deadenylation and decay.
An important question concerning the physiological implications of the proposed protein-protein interactions is whether the TTP family members and AUF1 proteins are expressed in the same tissues, cells, and subcellular compartments. At the tissue level, the portion of the AUF1p42 and p45 mRNA expressed from exon 7 appears to be expressed in all mouse tissues examined by the ENCODE-LICR deep sequencing project (see the UCSC Genome Browser). Expression was also noted in mouse embryonic stem cells and mouse embryonic fibroblasts. Similar expression levels for the corresponding exon of laAUF1 (Hnrnpdl) were seen in the same tissues and cell types. The widely expressed TTP family members (Zfp36, Zfp36l1, and Zfp36l2) were all expressed to varying extents in the same tissues and cells. For the placenta-specific TTP family member Zfp36l3, we examined our own deep sequencing data from mid-gestation mouse placenta 4 ; in this tissue, the exon 7 encoding the GY-rich domain of the AUF1 proteins and its equivalent exon in laAUF1 were also expressed at reasonable levels. We also examined expression in primary mouse macrophages, 5 the primary source of the excess TNF in the TTPdeficient mice. In unstimulated macrophages, relative average expression levels from the Affymetrix microarrays were 220, 1095, 1948, 255, and 1240 for TTP, ZFP36L1, ZFP36l2, AUF1, and IaAUF, respectively. 5 Neither AUF1 nor laAUF1 transcripts were significantly induced in response to LPS treatment, whereas TTP transcripts were increased by 6-fold and TNF transcripts 96-fold; ZFP36L1 and ZFP36L2 transcripts were down-regulated by 6-and 24-fold, respectively, in response to LPS. 5 Finally, although both TTP and AUF1 family members have been found to shuttle between the cytoplasm and nucleus under various conditions, when TTP and AUF1p45 were co-expressed in 293 cells as epitope-tagged proteins and immunostained, the expression was predominantly cytoplasmic in both cases and overlapped optically (data not shown). We conclude from this analysis that both TTP and AUF1 family proteins are most likely normally expressed under circumstances in which they could physically interact.
Binding of TTP family proteins to mRNA target sequences is only the first step in the control of mRNA stability by these proteins. Important questions left unanswered in these experiments include the effects of AUF1 binding on the physiological activities of the TTP family proteins and, conversely, the effects of TTP binding on the activities of the AUF1 proteins. This is particularly germane in the case of AUF1, as specific modulation of its levels in cells does not seem to affect the expression of many transcripts (44) . Both of these questions will be difficult to answer in physiological settings. Our attempt to address the first question in the present study only was able to show that modest increases in AUF1 concentration in cells did not have a demonstrable effect on the action of transfected, expressed TTP to promote decay of co-transfected target mRNA. One possible way to address these questions is to take advantage of the fact that the unstructured RNA "target" sequence of TTP family proteins binds to essentially only one face of the TZF domain structure (45) . It seems possible, even likely, that the GY domain of the larger AUF1 proteins binds to the TZF domain of TTP family members on a face that is distinct from the RNA binding surface, thereby influencing protein-RNA interactions. We have already identified a large number of TZF domain mutants that have a variety of effects on RNA binding, including many mutants that have minimal effect on RNA binding (37) 5 ; it is possible that some of these mutations could interfere with AUF1 binding. Another possibility would be to enforce the splicing out of exon 7 in the gene encoding the AUF1 family members, perhaps in knock-in mice, although this would still leave behind the intact laAUF1 protein. These possibilities are complicated by the data described here that the AUF1 proteins can also bind PABP, as previously demonstrated for TTP (17) ; analysis of the physiological effects of the TTP-AUF1 interactions will be greatly complicated by the many other proteins besides PABP that are known to interact with each.
The direct binding of AUF1 proteins to TTP may help explain other puzzling phenomena, such as the ability of TTP to promote the decay of non-polyadenylated mRNAs like histone mRNAs when an ARE TTP binding site has been introduced (7) . In this situation, the AUF1 proteins may help recruit other cellular exonucleases to participate in the decay of the nonpolyadenylated histone mRNAs.
One of the most interesting questions raised by these studies concerns the phenotype of the AUF1 KO mice (26, 46) . These animals appear remarkably normal under standard colony conditions but are extremely sensitive to LPS-induced toxicity. In addition, as in the case of macrophages derived from TTP-deficient mice, the AUF1-deficient macrophages exhibit stabilization of LPS-induced TNF transcripts. Could some aspects of this phenotype be due to the role proposed here of AUF1 as a potential mediator of TTP action in vivo? This question can probably be addressed by conducting epistasis experiments with various allelic combinations of the TTP and AUF1 KO mice.
The activity of TTP family members can be regulated at various levels, including protein binding, gene expression (including both gene transcription and mRNA decay), nucleocytoplasmic shuttling, phosphorylation, and others. Previously described TTP-protein interactions include exosome components (43), decapping, and exonuclease proteins such as Ccr4, Dcp, and Xrn1 (47), protein kinase MK2 (48), the scaffold protein 14-3-3 (49), RISC components Ago/eiF2C (50), nuclear pore protein Nup214 (51), PP2A (52), CIN85, PABP, and nucleolin (17) . In addition, many other potential interactions were identified in our two-hybrid screen and still remain to be validated. It will require considerable further work to determine the binding sites for each of these proposed complexes on the TTP protein and its partners as well as the regulation of each complex by some of the factors enumerated above.
